-DOCSTART- -X- O
Allotransplantation -X- _ O
and -X- _ O
xenotransplantation -X- _ O
may -X- _ O
be -X- _ O
associated -X- _ O
with -X- _ O
the -X- _ O
transmission -X- _ O
of -X- _ O
pathogens -X- _ O
from -X- _ O
the -X- _ O
donor -X- _ O
to -X- _ O
the -X- _ O
recipient. -X- _ O
Whereas -X- _ O
in -X- _ O
the -X- _ O
case -X- _ O
of -X- _ O
allotransplantation -X- _ O
the -X- _ O
transmitted -X- _ O
microorganisms -X- _ O
and -X- _ O
their -X- _ O
pathogenic -X- _ O
effect -X- _ O
are -X- _ O
well -X- _ O
characterized -X- _ O
, -X- _ O
the -X- _ O
possible -X- _ O
influence -X- _ O
of -X- _ O
porcine -X- _ B-Intervention
microorganisms -X- _ I-Intervention
on -X- _ O
humans -X- _ O
is -X- _ O
mostly -X- _ O
unknown. -X- _ O
Porcine -X- _ O
circoviruses -X- _ O
( -X- _ O
PCVs -X- _ O
) -X- _ O
are -X- _ O
common -X- _ O
in -X- _ O
pig -X- _ B-Patient
breeds -X- _ I-Patient
and -X- _ O
they -X- _ O
belong -X- _ O
to -X- _ O
porcine -X- _ B-Intervention
microorganisms -X- _ I-Intervention
that -X- _ O
still -X- _ O
have -X- _ O
not -X- _ O
been -X- _ O
fully -X- _ O
addressed -X- _ O
in -X- _ O
terms -X- _ O
of -X- _ O
evaluating -X- _ O
the -X- _ O
potential -X- _ O
risk -X- _ O
of -X- _ O
xenotransplantation -X- _ O
using -X- _ O
pig -X- _ O
cells -X- _ O
, -X- _ O
tissues -X- _ O
, -X- _ O
and -X- _ O
organs. -X- _ O
Two -X- _ O
types -X- _ O
of -X- _ O
PCVs -X- _ O
are -X- _ O
known -X- _ O
: -X- _ O
porcine -X- _ B-Intervention
circovirus -X- _ I-Intervention
( -X- _ I-Intervention
PCV -X- _ I-Intervention
) -X- _ I-Intervention
1 -X- _ I-Intervention
and -X- _ I-Intervention
PCV2. -X- _ I-Intervention
Whereas -X- _ O
PCV1 -X- _ B-Outcome
is -X- _ I-Outcome
apathogenic -X- _ I-Outcome
in -X- _ I-Outcome
pigs -X- _ I-Outcome
, -X- _ I-Outcome
PCV2 -X- _ I-Outcome
may -X- _ I-Outcome
induce -X- _ I-Outcome
severe -X- _ I-Outcome
pig -X- _ I-Outcome
diseases. -X- _ I-Outcome
Although -X- _ O
most -X- _ O
pigs -X- _ O
are -X- _ O
subclinically -X- _ O
infected -X- _ O
, -X- _ O
we -X- _ O
do -X- _ O
not -X- _ O
know -X- _ O
whether -X- _ O
this -X- _ O
infection -X- _ O
impairs -X- _ O
pig -X- _ O
transplant -X- _ O
functionality -X- _ O
, -X- _ O
particularly -X- _ O
because -X- _ O
PCV2 -X- _ O
is -X- _ O
immunosuppressive. -X- _ O
In -X- _ O
addition -X- _ O
, -X- _ O
vaccination -X- _ O
against -X- _ O
PCV2 -X- _ O
is -X- _ O
able -X- _ O
to -X- _ O
prevent -X- _ O
diseases -X- _ O
, -X- _ O
but -X- _ O
in -X- _ O
most -X- _ O
cases -X- _ O
not -X- _ O
transmission -X- _ O
of -X- _ O
the -X- _ O
virus. -X- _ O
Therefore -X- _ O
, -X- _ O
PCV2 -X- _ B-Outcome
has -X- _ I-Outcome
to -X- _ I-Outcome
be -X- _ I-Outcome
eliminated -X- _ I-Outcome
to -X- _ I-Outcome
obtain -X- _ I-Outcome
xenotransplants -X- _ I-Outcome
from -X- _ I-Outcome
uninfected -X- _ I-Outcome
healthy -X- _ I-Outcome
animals. -X- _ I-Outcome
Although -X- _ O
there -X- _ O
is -X- _ O
evidence -X- _ O
that -X- _ O
PCV2 -X- _ O
does -X- _ O
not -X- _ O
infect—at -X- _ O
least -X- _ O
immunocompetent—humans -X- _ O
, -X- _ O
animals -X- _ O
should -X- _ O
be -X- _ O
screened -X- _ O
using -X- _ O
sensitive -X- _ O
methods -X- _ O
to -X- _ O
ensure -X- _ O
virus -X- _ O
elimination -X- _ O
by -X- _ O
selection -X- _ O
, -X- _ O
Cesarean -X- _ O
delivery -X- _ O
, -X- _ O
vaccination -X- _ O
, -X- _ O
or -X- _ O
embryo -X- _ O
transfer -X- _ O
. -X- _ O

